Ann: Percheron launches post-trial access program, page-59

Completely agree Joe.

I was initially annoyed at the cr price but after reading the quarterly, it was necessary. Look at how disappointed we all were seeing a cr after the great run we had. Imagine having great results and then seeing a trading halt mid run. In the end the price is either going to tank or fly after results come out and in either scenario I’d rather the company have cash.

I think we have to accept that it’s happened now, it was not ideal or at a price we wanted but we need to put it behind us and focus on the upcoming results. The more research I do the more I think they must be seeing some positive outcomes to continue the drug after the trial ends.

Anyways, I’m excited. Been holding this stock for nearly 5 years now and finally coming to the pointy end.

Like I’ve said before, I swear some on here want this stock to fail, I really don’t get it.